Broxaldine

Broxaldine (CAS No.: 3684-46-6) is a synthetic antimicrobial agent primarily classified as an antiprotozoal compound with additional antibacterial and antifungal activities, making it of interest in infectious disease research and drug repurposing studies. It has demonstrated inhibitory activity against Clostridium difficile at low micromolar concentrations and exhibits antifungal effects, as well as the ability to reduce the viability of parasitic larvae such as Schistosoma mansoni, supporting its broad-spectrum antiparasitic and antimicrobial profile. Although its precise molecular targets and signaling pathways have not been fully elucidated, its biological activity suggests interference with essential microbial or parasitic cellular processes, positioning it as a candidate for mechanistic studies aimed at identifying novel anti-infective targets. In vitro studies typically report activity in the low micromolar range, and its effects have been evaluated in microbial cultures and parasite viability assays. Broxaldine is commonly utilized in screening platforms and experimental infection models to explore antimicrobial efficacy, combination therapies, and structure–activity relationships, with applied concentrations varying according to specific experimental designs and research objectives.